2''-O-Rhamnosylicariside IICAS# 135293-13-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 135293-13-9 | SDF | Download SDF |
PubChem ID | 5318987 | Appearance | Yellow powder |
Formula | C33H40O14 | M.Wt | 660.7 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one | ||
SMILES | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O)O)C5=CC=C(C=C5)OC)C)O)O)O)O)O | ||
Standard InChIKey | TVBJKPLTBPGHDJ-ZJTKNEERSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1.2"-O-Rhamnosylicariside II shows potent inhibitory activities on osteoclast-like cell formation at a concentration of 2 uM without toxic effects. 2. 2″-O-Rhamnosylicariside II shows potent antioxidant activity, with IC50 values of 11.5 ug/mL and 90.5 uM. |
2''-O-Rhamnosylicariside II Dilution Calculator
2''-O-Rhamnosylicariside II Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5135 mL | 7.5677 mL | 15.1355 mL | 30.2709 mL | 37.8387 mL |
5 mM | 0.3027 mL | 1.5135 mL | 3.0271 mL | 6.0542 mL | 7.5677 mL |
10 mM | 0.1514 mL | 0.7568 mL | 1.5135 mL | 3.0271 mL | 3.7839 mL |
50 mM | 0.0303 mL | 0.1514 mL | 0.3027 mL | 0.6054 mL | 0.7568 mL |
100 mM | 0.0151 mL | 0.0757 mL | 0.1514 mL | 0.3027 mL | 0.3784 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- EW-7197
Catalog No.:BCC6467
CAS No.:1352608-82-2
- Pulchinenoside B
Catalog No.:BCN6554
CAS No.:135247-95-9
- Trijuganone C
Catalog No.:BCN3685
CAS No.:135247-94-8
- Pindolol
Catalog No.:BCC6881
CAS No.:13523-86-9
- AZD6738
Catalog No.:BCC6505
CAS No.:1352226-88-0
- Schineolignin B
Catalog No.:BCN3623
CAS No.:1352185-26-2
- AMG232
Catalog No.:BCC3992
CAS No.:1352066-68-2
- 3Beta-acetoxy-eupha-7,25-dien-24(R)-ol
Catalog No.:BCN1580
CAS No.:1352001-09-2
- Sanggenol P
Catalog No.:BCN4766
CAS No.:1351931-30-0
- H-Val-OtBu.HCl
Catalog No.:BCC3143
CAS No.:13518-40-6
- GNE-7915
Catalog No.:BCC5304
CAS No.:1351761-44-8
- HG-10-102-01
Catalog No.:BCC4271
CAS No.:1351758-81-0
- MEN 10376
Catalog No.:BCC7133
CAS No.:135306-85-3
- 8,8'-Bibaicalein
Catalog No.:BCN6549
CAS No.:135309-02-3
- 5,7,3',4'-Tetrahydroxy-3-methoxy-8,5'-diprenylflavone
Catalog No.:BCN6848
CAS No.:1353676-65-9
- Isojasminin
Catalog No.:BCN7492
CAS No.:135378-08-4
- 4'-Hydroxyisojasminin
Catalog No.:BCN7383
CAS No.:135378-09-5
- 12alpha-Methoxygrandiflorenic acid
Catalog No.:BCN7771
CAS No.:135383-94-7
- 8-Prenyldaidzein
Catalog No.:BCN4711
CAS No.:135384-00-8
- CX-6258 hydrochloride hydrate
Catalog No.:BCC1505
CAS No.:1353858-99-7
- Bullatine A
Catalog No.:BCN2374
CAS No.:1354-84-3
- KH CB19
Catalog No.:BCC6135
CAS No.:1354037-26-5
- ACT 335827
Catalog No.:BCC6346
CAS No.:1354039-86-3
- trans-Ned 19
Catalog No.:BCC7825
CAS No.:1354235-96-3
The Toxicity and Metabolism Properties of Herba Epimedii Flavonoids on Laval and Adult Zebrafish.[Pubmed:30941194]
Evid Based Complement Alternat Med. 2019 Mar 3;2019:3745051.
Zebrafish is being increasingly used for metabolism and toxicity assessment. The drugs consumed in zebrafish metabolism studies are far less than those used in rat studies. In our study, zebrafish embryos were exposed to icariin, Baohuoside I (BI), Epimedin A (EA), Epimedin B (EB), Epimedin C (EC), Sagittatoside A (SA), Sagittatoside B (SB), and 2''-O-rhamnosylicariside II (SC), respectively, to examine the toxicity and metabolic profiles of these flavonoids. The order of toxicity was SC, SB > EC, SA > BI, icariin, EA, EB. After 24 h exposure to SB and SC, the mortality of zebrafish larvae reached 100% and yolk sac swollen was obvious. Both SC and SB caused severe hepatocellular vacuolization and liver cells degeneration in adult zebrafish after 15 consecutive days' treatment. The metabolic profiles of these flavonoids with trace amount were also monitored in larvae. BI was the common metabolite shared by icariin, EA, EB, SA, and SB, via deglycosylation. Both BI and SC remained as the prototype in the medium, suggesting that it is hard for BI and SC to cleave the rhamnose residue. EC was metabolized into SC and BI in zebrafish, inferring that SC might be responsible for the toxicity observed in EC group. The metabolites of icariin, EA, EB, EC, and BI in zebrafish larvae coincided with results from rats and intestinal flora. These data support the use of this system as a surrogate in predicting metabolites and hepatotoxicity risk, especially for TCM compound with trace amount.